Safety and effectiveness of disease-modifying therapies after switching from natalizumab
Zeineddine, Maya, Al-Roughani, Raed, Farouk Ahmed, Samar, Khoury, Samia, El-Ayoubi, Nabil, Al-Mahdawi, Akram, Al-Khabouri, Jaber, Al-Asmi, Abdullah, Chentouf, Amina, Inshasi, Jihad, Gouider, Riadh, Mrabet, Saloua, Shalaby, Nevin, Massouh, Joelle, Mohamed Ramzy Hasan Mohamed, Farah, Al-Hajje, Amal, Salameh, Pascale, Dimassi, Hani, Boumediene, Farid, Yamout, Bassem
Published in Multiple sclerosis (01.07.2024)
Published in Multiple sclerosis (01.07.2024)
Get more information
Journal Article
Factors affecting MS patients’ health-related quality of life and measurement challenges in Lebanon and the MENA region
Farran, Natali, Safieddine, Batoul R, Bayram, Mariam, Abi Hanna, Tracy, Massouh, Joelle, AlKhawaja, Mona, Tamim, Hani, Darwish, Hala
Published in Multiple sclerosis journal - experimental, translational and clinical (01.01.2020)
Published in Multiple sclerosis journal - experimental, translational and clinical (01.01.2020)
Get full text
Journal Article
Nurses’ stories from Beirut: The 2020 explosive disaster on top of a pandemic and economic crises
Jabbour, Rima, Harakeh, Miray, Dakessian Sailan, Silva, Nassar, Vicky, Tashjian, Hera, Massouh, Joelle, Massouh, Angela, Puzantian, Houry, Darwish, Hala
Published in International Nursing Review (01.03.2021)
Published in International Nursing Review (01.03.2021)
Get full text
Journal Article
Web Resource
Skin warts during fingolimod treatment in patients with multiple sclerosis
Jaafar, Nesreen, Zeineddine, Maya, Massouh, Joelle, Yamout, Bassem I.
Published in Multiple sclerosis and related disorders (01.11.2019)
Published in Multiple sclerosis and related disorders (01.11.2019)
Get full text
Journal Article
Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study
Zeineddine, Maya, Al-Hajje, Amal, Salameh, Pascale, Massouh, Joelle, Saab, Georges, Al-Roughani, Raed, Ahmed, Samar Farouk, Al-Mahdawi, Akram, Shalaby, Nevin, Inshasi, Jihad, Sahraian, Mohamad Ali, Gouider, Riadh, Mrabet, Saloua, Al-Khabouri, Jaber, Shayganneja, Vahid, Chentouf, Amina, Boumediene, Farid, Yamout, Bassem
Published in Multiple sclerosis and related disorders (01.10.2024)
Published in Multiple sclerosis and related disorders (01.10.2024)
Get full text
Journal Article
Multiple Sclerosis Specialized Nurses in Saudi Arabia: Challenge, and Opportunities
Alarieh, Rola, Balegh, Aida, Khan, Arij, Mejally, Asmaa, Almaghrabi, Fatima, Massouh, Joelle, Saleh, Omar, Nazmi, Ouhoud, Bukhari, Qamar, Sulague, Richel, Almaymani, Sawsan, Alsaggaf, Waad, Boghdady, Ahmed El
Published in Multiple sclerosis and related disorders (01.03.2022)
Published in Multiple sclerosis and related disorders (01.03.2022)
Get full text
Journal Article
Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of COVID-19 in Multiple Sclerosis: A MENACTRIMS Registry Based Study
Zeineddine, Maya, Boumediene, Farid, Al-Hajje, Amal, Salameh, Pascale, Massouh, Joelle, Saab, Georges, Al-Roughani, Raed, Al-Mahdawi, Akram, Shalaby, Nevin, Inshasi, Jihad, Sahraian, Mohamad Ali, Gouider, Riadh, Mrabet, Saloua, Al-Khabouri, Jaber, Shaygannejad, Vahid, Chentouf, Amina, Yamout, Bassem
Published in Multiple sclerosis and related disorders (01.03.2023)
Published in Multiple sclerosis and related disorders (01.03.2023)
Get full text
Journal Article
Safety and Efficacy of Disease Modifying Therapies After Switching from Natalizumab: A MENACTRIMS Observational Study
Zeineddine, Maya, Al-Roughani, Raed, Khoury, Samia, El-Ayoubi, Nabil, Al-Mahdawi, Akram, Al-Khabouri, Jaber, Al-Asmi, Abdullah, Chentouf, Amina, Inshasi, Jihad, Gouider, Riadh, Mrabet, Saloua, Shalaby, Nevin, Massouh, Joelle, Al-Hajje, Amal, Salameh, Pascale, Dimassi, Hani, Boumediene, Farid, Yamout, Bassem
Published in Multiple sclerosis and related disorders (01.12.2023)
Published in Multiple sclerosis and related disorders (01.12.2023)
Get full text
Journal Article